"Schizophrenia is a severe mental health disorder, impacting a person’s ability to distinguish the imaginary from the reality. Characterized by hallucinations, delusions, and disorganized behavior, the disorder can be attributed to several causes, including genetic causes, behavioral and environmental. CMB Clinical Trials conducts clinical trials in San Diego for pharmaceutical companies to test the safety and effectiveness of new investigational medications. We conduct clinical trials to test the medications for various mental health conditions, including Bipolar Disorder, Schizophrenia, Depression, Anxiety, or ADHD."

During the past decade, CMB Clinical Trials conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "CMB Clinical Trials" are "Depressive Disorder, Major" (2 trials) and "Depressive Disorder, Treatment-Resistant" (1 trials). Many other conditions were trialed in "CMB Clinical Trials" in a lesser frequency.

Most popular intervention types in "CMB Clinical Trials" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Aticaprant" (1 trials), "Esketamine 56 mg" (1 trials), "Esketamine 84 mg" (1 trials), "Matching placebo to Quetiapine XR" (1 trials) and "Matching placebo to Seltorexant" (1 trials). Other intervention names were less common.

The vast majority of trials in "CMB Clinical Trials" are 3 trials for "All" genders.

Currently, there are NaN active trials in "CMB Clinical Trials". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in CMB Clinical Trials, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CMB Clinical Trials, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".